Terpenoid Therapeutics (United States)
- Research works
- 1 fractional, all time
- Citations
- 24 34.3 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 29% world 28%
Not ranked overall: Terpenoid Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Terpenoid Therapeutics (United States) publish most on?
By volume: Ubiquitin and proteasome pathways, Plant biochemistry and biosynthesis, Retinoids in leukemia and cellular processes and Complement system in diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ubiquitin and proteasome pathways Molecular Biology 0 works
- 2 Plant biochemistry and biosynthesis Molecular Biology 0 works
- 3 Retinoids in leukemia and cellular processes Molecular Biology 0 works
- 4 Complement system in diseases Immunology 0 works
- 5 T-cell and B-cell Immunology Immunology 0 works
- 6 Immune Cell Function and Interaction Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Coralville
- Integrated DNA Technologies (United States)
- Vida Diagnostics (United States)
- Cellular Engineering Technologies (United States)
- ASL Analytical (United States)
- Medical Imaging Applications (United States)
- Viewpoint Molecular Targeting (United States)
- Iowa Children's Museum
- Viz-Tek (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.